Re-Immunization with Polysaccharide 23-Valent Pneumococcal Vaccine (Pneu-P-23 )

This statement will supplement previous pneumococcal statements and provide the evidence used to determine the optimal time between initial vaccination with polysaccharide 23-valent pneumococcal vaccine (Pneu-P-23) and subsequent booster doses to protect against invasive pneumococcal disease in those at highest risk for IPD.